Table 1.

Predictors of GUD Detected in the 6 Months after ART Initiation

Variable	Univariate Analysis		Multivariate Analysis
	Odds Ratio (95% CI)	P value	Odds Ratio (95% CI)	P value
Timepoint:
Baseline	Reference		Reference
Month 1	1.9 (1.0–3.4)	0.04	1.9 (1.0–3.6)	0.04
Month 2	1.2 (0.6–2.4)	0.63	1.2 (0.6–2.4)	0.67
Month 3	0.6 (0.3–1.4)	0.29	0.6 (0.3–1.5)	0.30
Month 4	1.1 (0.5–2.4)	0.83	1.1 (0.5–2.5)	0.81
Month 5	0.8 (0.3–1.8)	0.58	0.8 (0.3–1.9)	0.60
Month 6	0.7 (0.3–1.6)	0.38	0.7 (0.3–1.7)	0.40
CD4 count:
<100 cells/µL	1.9 (1.1–3.4)	0.03	1.8 (1.0–3.4)	0.06
≥100 cells/µL	Reference		Reference
Clinical stage:
Stage 1	Reference		Reference
Stage 2	2.1 (0.7–6.0)	0.18	1.9 (0.7–5.0)	0.18
Stage 3	2.0 (0.8–5.2)	0.16	1.3 (0.5–3.1)	0.56
Stage 4	3.3 (1.1–9.8)	0.04	2.0 (0.7–5.6)	0.17
History of GUD, yes/no	3.9 (2.0–7.7)	<0.001	3.8 (1.9–7.7)	<0.001

CI = confidence interval